Clincosm LogoSign in Get a demo

Lymphoma, Follicular

Showing 1 - 25 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +4 more
  • Birmingham, United Kingdom
  • +5 more
Sep 18, 2023

Lymphoma, Follicular Trial (Mosunetuzumab)

Not yet recruiting
  • Lymphoma, Follicular
  • (no location specified)
May 8, 2023

People Living With HIV Treated With CD19-directed CAR T Cell

Active, not recruiting
  • Leukemia
  • +9 more
    • Philadelphia, Pennsylvania
      Pennsylvania Hospital
    Mar 29, 2023

    Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,

    Not yet recruiting
    • Mycosis Fungoides of Skin (Diagnosis)
    • +5 more
    • Med-Jet Injector
    • +4 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 17, 2023

    Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • JCAR017
    • +7 more
    • Duarte, California
    • +17 more
    Jan 13, 2023

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +12 more
    • Tucson, Arizona
      The University of Arizona Cancer Center
    Dec 13, 2022

    Relapsed or Refractory Follicular Lymphoma With Enhancer of

    Recruiting
    • Lymphoma, Follicular
    • Anjo-shi, Aichi, Japan
    • +174 more
    Dec 12, 2022

    Lymphoma, Follicular, Follicular Lymphoma Trial in Saint Louis (Mosunetuzumab, Polatuzumab vedotin)

    Recruiting
    • Lymphoma, Follicular
    • Follicular Lymphoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 14, 2022

    Long-term Ovarian Fertility in Patients Treated for Lymphoma.

    Not yet recruiting
    • Lymphoma, Follicular
      • (no location specified)
      Nov 7, 2022

      Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma Trial in United States (ADI-001, Fludarabine,

      Recruiting
      • Lymphoma, Follicular
      • +5 more
      • ADI-001
      • +2 more
      • Stanford, California
      • +6 more
      Oct 19, 2022

      Allogeneic Gamma Delta (?d) CAR T Cells

      Enrolling by invitation
      • Lymphoma, Follicular
      • +5 more
      • ADI-001
      • Stanford, California
      • +4 more
      Jun 7, 2022

      Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States

      Recruiting
      • Lymphoma, Non-Hodgkin
      • +3 more
        • Hot Springs, Arkansas
        • +12 more
        Apr 14, 2022

        Lymphoma, Follicular Trial in China (Abexinostat)

        Recruiting
        • Lymphoma, Follicular
        • Beijing, China
        • +25 more
        Mar 3, 2022

        Follicular Lymphoma, Lymphoma, Follicular Trial in United States (Zevalin Therapeutic Regimen, R-CVP)

        Terminated
        Has Results
        • Follicular Lymphoma
        • Lymphoma, Follicular
        • Zevalin Therapeutic Regimen
        • R-CVP
        • Jacksonville, Florida
        • +5 more
        Dec 16, 2021

        Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States

        Completed
        Has Results
        • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
        • +5 more
        • Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
        • GVHD prophylaxis
        • Duarte, California
        • +15 more
        Nov 2, 2021

        Lymphoma, Non-Hodgkin, Lymphoma, Large B-cell, Diffuse, Lymphoma, Follicular Trial in Canada, Germany, United States (TAK-659,

        Completed
        • Lymphoma, Non-Hodgkin
        • +2 more
        • Birmingham, Alabama
        • +14 more
        Aug 23, 2021

        NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)

        Completed
        • NHL
        • +17 more
        • veltuzumab
        • Savannah, Georgia
        • +4 more
        Aug 12, 2021

        Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Austria, Switzerland (BeEAM, BEAM)

        Completed
        • Lymphoma, Large B-Cell, Diffuse
        • +2 more
        • Linz, Austria
        • +3 more
        Jul 29, 2021

        Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine

        Active, not recruiting
        • Lymphoma, Non-Hodgkin
        • +5 more
        • Providence, Rhode Island
          Rhode Island Hospital and The Miriam Hospital
        Jul 19, 2021

        Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)

        Completed
        Has Results
        • Non-Hodgkin Lymphoma
        • +8 more
        • La Jolla, California
        • +10 more
        Apr 27, 2021

        Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)

        Completed
        Has Results
        • Lymphoma, Follicular
        • Scarborough, Maine
        • +3 more
        Apr 27, 2021

        Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Intermediate-Grade Trial in Munich (procedure, drug, other)

        Active, not recruiting
        • Lymphoma, Follicular
        • +2 more
        • FCM
        • +3 more
        • Munich, Germany
          German Low Grade Study Group (Glsg)
        May 6, 2021

        REVLIMID® Treatment of IPSS Low- or Intermediate-1-risk

        Recruiting
        • Myelodysplastic Syndromes
        • +2 more
        • Anyang, Korea, Republic of
        • +12 more
        Apr 6, 2021

        Study of Lymphoma in Asia

        Completed
        • Lymphoma, Follicular
        • +5 more
          • Hexi District, China
          • +3 more
          Nov 24, 2020

          Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (OT-82 Dose Escalation, OT-82 Dose Expansion)

          Recruiting
          • Lymphoma
          • +6 more
          • OT-82 Dose Escalation
          • OT-82 Dose Expansion
          • Birmingham, Alabama
          • +7 more
          Oct 22, 2020